e/Serotonin–norepinephrine–dopamine reuptake inhibitor

Information
has gloss	eng: A serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI), or triple reuptake inhibitor (TRI), is a drug which simultaneously acts as a reuptake inhibitor for the monoamine neurotransmitters serotonin (5-hydroxytryptamine (5-HT), norepinephrine (noradrenaline) and epinephrine (adrenaline), and dopamine, by blocking the action of the serotonin transporter (SERT), norepinephrine transporter (NET), and dopamine transporter (DAT), respectively. This in turn leads to increased extracellular concentrations of these neurotransmitters and therefore an increase in serotonergic, noradrenergic or adrenergic, and dopaminergic neurotransmission.
lexicalization	eng: Serotonin-norepinephrine-dopamine reuptake inhibitors
lexicalization	eng: Serotonin-norepinephrine-dopamine reuptake inhibitor
lexicalization	eng: Serotonin-norepinephrine-dopamine-reuptake-inhibitor
lexicalization	eng: Serotonin/Norepinephrine/Dopamine Reuptake Inhibitor
lexicalization	eng: Serotonin–norepinephrine–dopamine reuptake inhibitor
subclass of	(noun) a substance that retards or stops an activity inhibitor

Media
media:img	Triple Uptake Inhibitor.png